Improve Efficiency of Variant Screening for Biological Drugs
02 May 2013

In order to control the manufacturing of biological drugs efficiently, it is necessary to understand their physicochemical properties in the early stages and identify the important quality attributes. The need for screening multiple variants early in the process leads to an increased workload.

High resolution mass spectrometry is a useful tool to assess important attributes of those variants such as intact mass, termini sequences and glycosylation profile.

Software is available to automate these analyses and subsequent data processing thereby reducing the workload and increasing confidence in the results by minimizing manual steps.

Attend this webinar to discover:
•Methods to automate the analysis of intact and subunit level of therapeutic monoclonal antibodies
•Tools for rapid N- and C- terminal sequencing of biologic drugs
•Automated glycoprofiling and glycan analysis at the glycopeptide level

Bruker Daltonics

Show    per page
1 of 10 Page     1 2 3  ... Next 
A new approach to improving early characterization of therapeutic formulations - Viscosizer 2005 Sep 2014Read
An introduction to capillary rheometry - Evaluating material properties under process relevant conditions5 Sep 2014Read
Speed your way though your protein formulation screening by automating your measurements5 Sep 2014Read
Novel analytical technologies for product deformulation - Part 25 Sep 2014Read
Water treatment - Optimize coagulant dosing using zeta potential5 Sep 2014Read
Applications of rheology in the waxes, creams and emulsions arena5 Sep 2014Read
Avoiding Bottlenecks When Validating Your Laboratory Instrument and Information Systems20 Aug 2014Read
A New Concept in Metabolic Studies: How Personalized 'Sportomics' Bridges Bench and Clinical Science24 Jul 2014Read
Process development and optimisation using ambr250™ for mammalian and microbial processes2 Jul 2014Read
Why does ice cream taste smooth or gritty? It depends on the rheology!30 Jun 2014Read